NCHC Applauds Senate Finance Investigation of Drug Pricing
Statement from National Coalition on Health Care’s CEO John Rother on Senate Finance Committee leadership’s demand for transparency on the astronomical pricing of Gilead’s new hepatitis C drug Sovaldi.
“Over the past months, our efforts have been focused on shining light on unsustainable prices. We believe providing more transparency into how and why drugs are priced is critical to the long-term sustainability and innovation that is a hallmark of a strong health care system. We applaud Senator Grassley and Senator Wyden for undertaking this critical investigation of high prices for certain prescription drugs.”
See full press release: http://nchc.org/nchc-applauds-senate-finance-investigation-of-drug-pricing-2